Fremont (California) – December 10, 2018 —LifeSignals, a pioneer in advanced biomonitoring, and ImagineMed, a provider of advanced telemedicine and remote health monitoring, announced today a partnership to bring clinical-grade, wireless monitoring to patients, enabling them to have the dual comfort of more freedom and more precise, real-time monitoring of their health metrics.
This advancement in biomonitoring already has statistical proof of its power to transform patient care. ImagineMed’s subsidiary TeliStat™ deployed a centralized monitoring service in 7 skilled nursing facilities in New York State. The result: 30-day readmission rates decreased from the state average of 20% to just 5%. Now, with the addition of LifeSignals Wireless Biosensor, combined with ImagineMed’s MonitorMe technology, this highly effective monitoring can be delivered anywhere, saving money, improving the quality of care, and doing so in the comfort of a person’s home.
“LifeSignals is a game-changing technology. It can deliver continuous, clinical-grade monitoring of ECG from the patient’s home with a lightweight, comfortable, disposable biosensor. Our staff is able to monitor any abnormality, giving the patient confidence and eliminating unnecessary re-admissions,” said Dr. Anthony J. Bacchi, CEO, and Founder of ImagineMed.
The Next Wave in Biomonitoring
LifeSignals’ biomonitoring technology is at the forefront of what eventually will be the standard for best-in-class biomonitoring anywhere. Its multi-parameter biosensors can record ECG, respiration, and heart rate, and future versions will include SPO2, Temperature, and other parameters. Plus, the biosensors are disposable, inexpensive and they last for three to five days of continuous monitoring.
Another key differentiator is that LifeSignals’ biosensor is streamed three ways: 1. Raw data forms the basis for predictive analysis. 2. Live information streamed into the ImagineMed Monitoring Intervention Center so that staff can interact in real-time and in any emergency situation. 3. Data streamed into intelligent software to help analyze heart rhythm, for example, back to the monitoring device center. Clinicians can see a real stream of live information and the second stream of information from the computer, comparing the data, and seeing whether the rhythms are exactly as they thought they were.
“At LifeSignals we are combining the power of our wireless sensor technology with the flexibility of the cloud so that patients can free themselves from the confines of location-based monitoring, and at the same time, receive a real-time analysis of their health data at a level that did not exist before,” said LifeSignals Founder and CEO Surendar Magar.
“Cloud-based analytics will enable healthcare providers to provide data analysis of higher quality, and in real-time, thereby improving patient care,” he added.
Biomonitoring Future
As cloud-based biomonitoring becomes widespread with wireless biosensors, a variety of biodata from vast populations will be collected and available in databases. It will lead to effective AI algorithms that will assist healthcare staff, massively increasing productivity and diagnosis/treatment accuracy.
“Our early trial with LifeSignals was so successful that we are already looking at expanding the wireless sensor use to our other facilities. Patients are receiving better real-time monitoring and enjoying the freedom of being untethered from a hospital environment, it’s an enormous quality-of-life improvement,” said Dr. Bacchi.
About LifeSignals, Inc.
LifeSignals (formerly HMicro Inc.) is the Silicon Valley-based creator and producer of the patented LifeSignals Processor (LSP), a semiconductor platform designed to faithfully capture and communicate vital life signals from humans and animals to the cloud. LifeSignals works together with its growing ecosystem of technology and services partners, to serve established OEMs and early-stage innovators in human and animal healthcare, senior living, worker safety, and other life-critical markets. LifeSignals is a venture capital-backed, a fabless semiconductor company, enabled by equity investments from Flex, Uniquest, Dreamtech, Renew Group, Seraph Capital, Xseed Capital, and Reddy Capital. Further information can be found at www.lifesignals.com.
About ImagineMed
ImagineMed provides comprehensive telemedicine and remote health monitoring solutions that reduce emergency room visits and hospital admissions to facilitate aging at home. ImagineMed combines proprietary, state-of-the-art biosensors and telemedicine monitoring technology with 24/7 real-time hemodynamic and predictive analytics for interpretation and intervention by a multidisciplinary team located in a Monitoring Intervention Center (MIC). For more information, visit ImagineMed at https://imagine-med.com/
Media Contacts for LifeSignals
PRxDigital
Jennifer Spoerri – 415-577-0171
